These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 4838281)

  • 1. Prostaglandin synthetase activity in the renal medulla of normal and hypertensive rats.
    Grodzińska L; Schrör K; Wartner U; Förster W; Gryglewski R
    Pol J Pharmacol Pharm; 1974; 26(1):229-35. PubMed ID: 4838281
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of prostaglandin content and prostaglandin synthetase activity in the renal medulla of renal hypertensive and spontaneously hypertensive rats.
    Somova L
    Acta Biol Med Ger; 1976; 35(8-9):1207-11. PubMed ID: 827170
    [No Abstract]   [Full Text] [Related]  

  • 3. Biosynthesis of prostaglandins in rabbit renal cortex.
    Pong SS; Levine L
    Res Commun Chem Pathol Pharmacol; 1976 Jan; 13(1):115-23. PubMed ID: 815974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of indomethacin on the prostaglandins synthetase system in rat tissues in vivo.
    Dembińska-Kieć A; Grodzińska L; Piotrowicz J
    Pol J Pharmacol Pharm; 1974; 26(1):79-82. PubMed ID: 4858008
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostaglandins and renal function.
    McGiff JC; Crowshaw K; Itskovitz HD
    Fed Proc; 1974 Jan; 33(1):39-47. PubMed ID: 4359037
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostaglandin synthesis in membrane fractions from the rabbit renal medulla.
    Bohman SO; Larsson C
    Acta Physiol Scand; 1975 Jun; 94(2):244-58. PubMed ID: 808103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin synthetase activity in kidney medulla during the development of experimental hypertension in the rat.
    Haux F; Ingerowski RM; Von Bruchhausen F
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):77-9. PubMed ID: 826839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the prostaglandin synthetase systems in ocular tissues by indomethacin.
    Bhattacherjee P; Eakins KE
    Br J Pharmacol; 1974 Feb; 50(2):227-30. PubMed ID: 4425761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional morphology of interstitial cells of the renal medulla after treatment with indomethacin and unilateral nephrectomy].
    Zufarov KA; Gontmakher VM; Khamraev AA
    Arkh Patol; 1987; 49(1):9-14. PubMed ID: 3827642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible significance of renal prostaglandins for renin release and blood pressure control.
    Weber PC; Scherer B; Siess W; Held E; Schnermann J
    Adv Prostaglandin Thromboxane Res; 1980; 7():1067-77. PubMed ID: 6989178
    [No Abstract]   [Full Text] [Related]  

  • 11. Derivation of antihypertensive neutral renomedullary lipid from renal venous effluent.
    Muirhead EE; Byers LW; Desiderio DM; Pitcock JA; Brooks B; Brown PS; Brosius WL
    J Lab Clin Med; 1982 Jan; 99(1):64-75. PubMed ID: 6798154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a renal prostaglandin on distribution of blood flow in the isolated canine kidney.
    Itskovitz HD; Terragno NA; McGiff JC
    Circ Res; 1974 Jun; 34(6):770-6. PubMed ID: 4832702
    [No Abstract]   [Full Text] [Related]  

  • 13. Decreased prostaglandin synthetase activity during kidney regeneration after folic acid or 2,4,5-triamino-6-styrylpyrimidine application.
    Ingerowski RM; Haux F; Bruchhausen F
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jun; 298(2):157-62. PubMed ID: 407480
    [No Abstract]   [Full Text] [Related]  

  • 14. Alterations of linoleic, arachidonic and eicosapentaenoic acids in renal cortex and medulla of SHR during the onset of hypertension.
    Singer P; Wirth M; Gerike U; Gödicke W; Moritz V
    Biomed Biochim Acta; 1984; 43(8-9):S247-50. PubMed ID: 6097234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
    Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
    Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin-forming cyclooxygenase in renal medulla of spontaneously hypertensive rats during development.
    Stygles VG; Smith WL; Reinke DA; Hook JB
    Biol Neonate; 1978; 33(5-6):309-13. PubMed ID: 99182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension produced by chemical renal medullectomy or partial nephrectomy in the rat: comparison of renal function and plasma volume.
    Taverner D; Bing RF; Swales JD; Thurston H
    J Hypertens Suppl; 1984 Dec; 2(3):S367-9. PubMed ID: 6599684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vasodepressor function of the kidney: prostaglandin E2 is not the principal vasodepressor lipid of the renal medulla.
    Glodny B; Pauli GF
    Acta Physiol (Oxf); 2006 Jul; 187(3):419-30. PubMed ID: 16776667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal cyclo-oxygenase and lipoxygenase products in health and disease.
    Dunn MJ; Scharschmidt LA; Lianos EA; Konieczkowski M
    Clin Physiol Biochem; 1984; 2(2-3):91-100. PubMed ID: 6435931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs which inhibit prostaglandin biosynthesis.
    Flower RJ
    Pharmacol Rev; 1974 Mar; 26(1):33-67. PubMed ID: 4208101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.